Comparing Symptomatic and Asymptomatic Carotid Artery Atherosclerosis in Patients With Bilateral Carotid Vulnerable Plaques Using Magnetic Resonance Imaging
Restricted accessResearch articleFirst published online February, 2022
Comparing Symptomatic and Asymptomatic Carotid Artery Atherosclerosis in Patients With Bilateral Carotid Vulnerable Plaques Using Magnetic Resonance Imaging
We compared plaque characteristics between symptomatic and asymptomatic sides in patients with bilateral carotid vulnerable plaques using magnetic resonance imaging (MRI). Participants (n = 67; mean age: 65.8 ± 7.7 years, 61 males) with bilateral carotid vulnerable plaques were included. Vulnerable plaques were characterized by intraplaque hemorrhage (IPH), large lipid-rich necrotic core (LRNC), or fibrous cap rupture (FCR) on MRI. Symptomatic vulnerable plaques showed greater plaque burden, LRNC volume (median: 221.4 vs 134.8 mm3, P = .003), IPH volume (median: 32.2 vs 22.5 mm3, P = .030), maximum percentage (Max%) LRNC (median: 51.3% vs 41.8%, P = .002), Max%IPH (median: 13.4% vs 9.5%, P = .022), cumulative slices of LRNC (median: 10 vs 8, P = .005), and more juxtaluminal IPH and/or thrombus (29.9% vs 6.0%, P = .001) and FCR (37.3% vs 16.4%, P = .007) than asymptomatic ones. After adjusting for plaque burden, differences in juxtaluminal IPH and/or thrombus (odds ratio [OR]: 5.49, 95% CI: 1.61-18.75, P = .007) and FCR (OR: 2.90, 95% CI: 1.16-7.24, P = .022) between bilateral sides remained statistically significant. For patients with bilateral carotid vulnerable plaques, symptomatic plaques had greater burden, more juxtaluminal IPH and/or thrombus, and FCR compared with asymptomatic ones. The differences in juxtaluminal IPH and/or thrombus and FCR between bilateral sides were independent of plaque burden.
LozanoRNaghaviMForemanK, et al.Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2095–128.
2.
KamelHNaviBBMerklerAE, et al.Reclassification of Ischemic Stroke Etiological Subtypes on the Basis of High-Risk Nonstenosing Carotid Plaque. Stroke. 2020;51:504–10.
3.
NaghaviMLibbyPFalkE, et al.From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003;108:1664–72.
4.
KurosakiYYoshidaKFukudaH, et al.Asymptomatic carotid T1-high-intense plaque as a risk factor for a subsequent cerebrovascular ischemic event. Cerebrovasc Dis. 2017;43:250–6.
5.
CaiYHeLYuanC, et al.Atherosclerotic plaque features and distribution in bilateral carotid arteries of asymptomatic elderly population: a 3D multicontrast MR vessel wall imaging study. Eur J Radiol. 2017;96:6–11.
6.
YamadaKYoshimuraSShirakawaM, et al.Asymptomatic moderate carotid artery stenosis with intraplaque hemorrhage: progression of degree of stenosis and new ischemic stroke. J Clin Neurosci. 2019;63:95–9.
7.
WangXSunJZhaoX, et al.Ipsilateral plaques display higher T1 signals than contralateral plaques in recently symptomatic patients with bilateral carotid intraplaque hemorrhage. Atherosclerosis. 2017;257:78–85.
8.
YuanCMitsumoriLMBeachKW, et al.Carotid atherosclerotic plaque: noninvasive MR characterization and identification of vulnerable lesions. Radiology. 2001;221:285–99.
9.
ZhaoXLiRHippeDS, et al.Chinese atherosclerosis risk evaluation (CARE II) study: a novel cross-sectional, multicentre study of the prevalence of high-risk atherosclerotic carotid plaque in Chinese patients with ischaemic cerebrovascular events-design and rationale. Stroke Vasc Neurol. 2017;2:15–20.
10.
KrishnaveniPGowdaVM. Assessing the Validity of Friedewald’s Formula and Anandraja’s Formula for Serum LDL-Cholesterol Calculation. J Clin Diagn Res. 2015;9:BC01-4.
11.
KerwinWXuDLiuF, et al.Magnetic resonance imaging of carotid atherosclerosis: plaque analysis. Top Magn Reson Imaging. 2007;18:371–8.
12.
ToussaintJFLaMuragliaGMSouthernJF, et al.Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation. 1996;94:932–8.
13.
CaiJHatsukamiTSFergusonMS, et al.Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation. 2002;106:1368–73.
14.
BarnettHJTaylorDWEliasziwM, et al.Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998;339:1415–25.
15.
LiFChenQChenZ, et al.Magnetic resonance imaging of plaque burden in vascular walls of the middle cerebral artery correlates with cerebral infarction. Curr Neurovasc Res. 2016;13:263–70.
16.
ManiVMuntnerPGiddingSS, et al.Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events. J Cardiovasc Magn Reson. 2009;11:10.
17.
GrimmJMSchindlerAFreilingerT, et al.Comparison of symptomatic and asymptomatic atherosclerotic carotid plaques using parallel imaging and 3 T black-blood in vivo CMR. J Cardiovasc Magn Reson. 2013;15:44.
18.
ZhaoXUnderhillHRZhaoQ, et al.Discriminating carotid atherosclerotic lesion severity by luminal stenosis and plaque burden a comparison utilizing high-resolution magnetic resonance imaging at 3.0 tesla. Stroke. 2011;42:347–53.
19.
YuanCZhangSPolissarNL, et al.Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation. 2002;105:181–5.
20.
ChuBKampschulteAFergusonMS, et al.Hemorrhage in the atherosclerotic carotid plaque: a high-resolution MRI study. Stroke. 2004;35:1079–84.
21.
SaamTCaiJMaL, et al.Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging. Radiology. 2006;240:464–72.
22.
ChistiakovDAOrekhovANBobryshevYV. Contribution of neovascularization and intraplaque hemorrhage to atherosclerotic plaque progression and instability. Acta Physiol. 2015;213:539–53.
23.
YeaglePL. Cholesterol and the cell membrane. Biochim Biophys Acta. 1985;822:267–87.
24.
WelgusHGCampbellEJCuryJD, et al.Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J Clin Invest. 1990;86:1496–502.
25.
TengZSadatUHuangY, et al.In vivo MRI-based 3D mechanical stress-strain profiles of carotid plaques with juxtaluminal plaque haemorrhage: an exploratory study for the mechanism of subsequent cerebrovascular events. Eur J Vasc Endovasc Surg. 2011;42:427–33.
26.
CarrSFarbAPearceWH, et al.Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg. 1996;23:755–65.
27.
OtaHYuWUnderhillHR, et al.Hemorrhage and large lipid-rich necrotic cores are independently associated with thin or ruptured fibrous caps: an in vivo 3 T MRI study. Arterioscler Thromb Vasc Biol. 2009;29:1696–701.
28.
DaviesMJThomasAC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J. 1985; 53:363–73.
29.
AbelaGSAzizK. Cholesterol crystals cause mechanical damage to biological membranes: a proposed mechanism of plaque rupture and erosion leading to arterial thrombosis. Clin Cardiol. 2005;28:413–20.
30.
AbelaGSAzizKVedreA, et al.Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes. Am J Cardiol. 2009;103:959–68.
31.
SunJBaluNHippeDS, et al.Subclinical carotid atherosclerosis: short-term natural history of lipid-rich necrotic core--a multicenter study with MR imaging. Radiology. 2013;268:61–8.
32.
MessasEGoudotGHallidayA, et al.Management of carotid stenosis for primary and secondary prevention of stroke: state-of-the-art 2020: a critical review. Eur Heart J Suppl. 2020;22: M35–42.
33.
WassermanBASharrettARLaiS, et al.Risk factor associations with the presence of a lipid core in carotid plaque of asymptomatic individuals using high-resolution MRI: the multi-ethnic study of atherosclerosis (MESA). Stroke. 2008;39:329–35.
34.
ZhaoXQDongLHatsukamiT, et al.MR Imaging of Carotid Plaque Composition During Lipid-Lowering Therapy A Prospective Assessment of Effect and Time Course. JACC Cardiovasc Imaging. 2011;4:977–86.
35.
FassaertLMMTimmermanNvan KoeverdenID, et al.Preoperative hypertension is associated with atherosclerotic intraplaque hemorrhage in patients undergoing carotid endarterectomy. Atherosclerosis. 2019;290:214–21.
36.
OgataAOhoKMatsumotoN, et al.Stabilization of vulnerable carotid plaques with proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab. Acta Neurochir (Wien). 2019;161:597–600.
37.
ChienJDFurtadoAChengSC, et al.Demographics of carotid atherosclerotic plaque features imaged by computed tomography. J Neuroradiol. 2013;40:1–10.
